Anzeige
Mehr »
Login
Sonntag, 26.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Der SILBER-STURM kommt - wie diese unterbewertete Firma die Investmentwelt aufmischt und Milliardenwerte hebt!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 904533 | ISIN: US74834L1008 | Ticker-Symbol: QDI
Tradegate
23.05.24
15:37 Uhr
129,75 Euro
-0,50
-0,38 %
Branche
Gesundheitswesen
Aktienmarkt
S&P 500
1-Jahres-Chart
QUEST DIAGNOSTICS INC Chart 1 Jahr
5-Tage-Chart
QUEST DIAGNOSTICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
128,90131,0018:40
129,75130,7024.05.
ACCESSWIRE
367 Leser
Artikel bewerten:
(2)

Quest Diagnostics: Working Together To Create a Healthier World, One Life at a Time

NORTHAMPTON, MA / ACCESSWIRE / October 3, 2023 / Quest Diagnostics

A letter from Quest Diagnostics Chairman, CEO, and President

Originally published in Quest Diagnostics Corporate Responsibility Report 2022

I'm pleased to share our 2022 Quest Diagnostics Corporate Responsibility Report.

Quest's Purpose-Working together to create a healthier world, one life at a time-is our North Star, underpinned by our Strategy (how we grow) and our Culture (how we work). Together, these 3 elements make up The Quest Way, informing our business decisions and priorities, how we operate as responsible corporate citizens, and the ways we create and maintain a growth-driven and inclusive workplace.

In 2022, we made progress on our Environmental, Social, and Governance (ESG) strategy. We set goals under our 4 ESG pillars and enhanced our ESG governance structure. We also built on the important work we are doing to address healthcare gaps in underserved communities through our Quest for Health Equity (Q4HE) initiative. To date, Quest and the Quest Diagnostics Foundation have committed approximately $30 million to 65 programs across the US and Puerto Rico.

Throughout 2022, we continued to deliver industry-leading diagnostic services and grow our base business while maintaining critical national capacity for ongoing COVID-19 testing services. We processed 208 million test requisitions and expanded our offerings by introducing 74 new tests. Our robust performance would not have been possible without the commitment and compassion of our approximately 49,000 colleagues, and I'm incredibly proud of how our team has worked together.

A key focus for us in 2022 was listening to and supporting our colleagues. We instituted the Stay Interview program to provide a new way for managers to engage proactively with their employees to build trust and more meaningful connections. We also launched our healthyMINDS approach to emotional well-being, partnering with Spring Health to provide high-quality and affordable mental health support to our employees and their dependents.

I'm excited about what lies ahead for us. Quest is well-positioned to play a significant role in the evolving healthcare ecosystem, and our investments in the areas of molecular genomics/oncology and consumer health are taking us into new and energizing territory. I look forward to sharing our achievements as we deliver on our commitment to helping to make this a healthier world.

In good health,

Jim Davis

Read more

Jim Davis, Chairman, CEO, and President

View additional multimedia and more ESG storytelling from Quest Diagnostics on 3blmedia.com.

Contact Info:
Spokesperson: Quest Diagnostics
Website: https://www.3blmedia.com/profiles/quest-diagnostics
Email: info@3blmedia.com

SOURCE: Quest Diagnostics

View source version on accesswire.com:
https://www.accesswire.com/789698/working-together-to-create-a-healthier-world-one-life-at-a-time

KI-Champions: 3 Top-Werte, die Ihr Portfolio revolutionieren
Fordern Sie jetzt den brandneuen kostenfreien Sonderreport an und erfahren Sie, wie Sie von den enormen Wachstumschancen im Bereich Künstliche Intelligenz profitieren können - 100 % kostenlos.
Hier klicken
© 2023 ACCESSWIRE
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.